RESEARCH TRIANGLE PARK, N.C., April 10, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics has named Roger Ilagan, PhD as its new Chief Scientific Officer (CSO). Responsible for guiding the biologic ...

“I am excited to accept this new role at Merakris Therapeutics and continue our work pioneering cell-free regenerative medicine to patients in need. By leveraging the extraordinary healing ...

As CSO, Dr. Ilagan will continue to spearhead the advancement of cell-free biologic therapies from immunologically privileged tissues to regenerative medicine drugs for complex cutaneous wounds ...

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has signed an exclusive distribution ...

Company reports record preliminary fourth quarter net revenue of $102.9 Million, contributing to a total of $301.8 Million in revenue for ...

The goal of regenerative medicine is to promote regeneration or constructive remodeling of the host tissues, by facilitating or enabling the endogenous regeneration, or delivering exogenous cells ...

The ongoing stigma and politicization of HIV/AIDS may not only hamper the national goal of ending the HIV epidemic but also lead to less or no preventive care for many people.

DelveInsight's "ENTYVIO Market Size, Forecast, and Market Insight Report" highlights the details around ENTYVIO, a gut-selective ...

As a small business owner, Liz understands the unique challenges entrepreneurs face. Well-versed in the digital landscape, she combines real-world experience in website design, building e-commerce ...

Viromed Medical AG: Exclusive distribution partnership with AMAMUS Vet for the cold plasma medical device ViroCAP® VET for veterinary use ...

Home-grown designers mark the Republic’s diamond jubilee at Milan Design Week 2025. Read more at straitstimes.com. Read more ...